Metagenomic editing of commensal bacteria in vivo using CRISPR-associated transposases
Science · 13.11.2025 · 390 (6774)
DOI: 10.1126/science.adx7604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 13.11.2025. Verfasst von Diego Rivera Gelsinger und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Biology, Columbia University, New York, NY, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Gene Editing, Bacteroides, CRISPR-Cas Systems. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
Although metagenomic sequencing has revealed a rich microbial biodiversity in the mammalian gut, methods to genetically alter specific species in the microbiome are highly limited. Here, we introduce Metagenomic Editing (MetaEdit) as a platform technology for microbiome engineering that uses optimized CRISPR-associated transposases delivered by a broadly conjugative vector to directly modify diverse native commensal bacteria from mice and humans with new pathways at single-nucleotide genomic resolution. Using MetaEdit, we achieved in vivo genetic capture of native murine Bacteroides by integrating a metabolic payload that enables tunable growth control in the mammalian gut with dietary inulin. We further show in vivo editing of segmented filamentous bacteria, an immunomodulatory small-intestinal microbial species recalcitrant to cultivation. Collectively, this work provides a paradigm to precisely manipulate individual bacteria in native communities across gigabases of their metagenomic repertoire.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Systems Biology, Columbia University, New York, NY, USA.
- Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA.
- Department of Microbiology and Immunology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
- Department of Biological Sciences, Columbia University, New York, NY, USA.
- Department of Molecular Pharmacology and Therapeutics, Columbia University, New York, NY, USA.
- Howard Hughes Medical Institute, Columbia University, New York, NY, USA.
ORCID-Profile: Diego Rivera Gelsinger, Carlotta Ronda, Om B Kar, Madeline Edwards, Yiming Huang, Chrystal F Mavros, Yiwei Sun, Tyler Perdue, Phuc Leo Vo, Ivaylo I Ivanov, Samuel H Sternberg, Harris H Wang
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NHGRI NIH HHS
- NIDDK NIH HHS
- Howard Hughes Medical Institute
- NIBIB NIH HHS
- Burroughs Wellcome Fund
- Wellcome
Zitieren
APA
Gelsinger, D. R., Ronda, C., Ma, J., Kar, O. B., Edwards, M., Huang, Y., Mavros, C. F., Sun, Y., Perdue, T., Vo, P. L., Ivanov, I. I., Sternberg, S. H., & Wang, H. H. (2025). Metagenomic editing of commensal bacteria in vivo using CRISPR-associated transposases. Science, 390(6774). https://doi.org/10.1126/science.adx7604
Vancouver
Gelsinger DR, Ronda C, Ma J, Kar OB, Edwards M, Huang Y, et al. Metagenomic editing of commensal bacteria in vivo using CRISPR-associated transposases. Science. 2025;390(6774). doi:10.1126/science.adx7604
BibTeX
@article{Gelsinger2025,
author = {Gelsinger, Diego Rivera and Ronda, Carlotta and Ma, Junjie and Kar, Om B and Edwards, Madeline and Huang, Yiming and Mavros, Chrystal F and Sun, Yiwei and Perdue, Tyler and Vo, Phuc Leo and Ivanov, Ivaylo I and Sternberg, Samuel H and Wang, Harris H},
title = {Metagenomic editing of commensal bacteria in vivo using CRISPR-associated transposases},
journal = {Science},
year = {2025},
volume = {390},
number = {6774},
doi = {10.1126/science.adx7604}
}
EUVIMED